The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127219353 12721935 3 F 20160802 20160830 20160907 20160913 EXP NO-FRESENIUS KABI-FK201605381 FRESENIUS KABI 0.00 M Y 0.00000 20160913 OT NO NO

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127219353 12721935 1 PS OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION OXALIPLATIN 1 Intravenous (not otherwise specified) U UNKNOWN 78810 153 MG CONCENTRATE FOR SOLUTION FOR INFUSION
127219353 12721935 2 SS OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION OXALIPLATIN 1 Intravenous (not otherwise specified) U UNKNOWN 78810 153 MG CONCENTRATE FOR SOLUTION FOR INFUSION
127219353 12721935 3 SS OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION OXALIPLATIN 1 Intravenous (not otherwise specified) U UNKNOWN 0 153 MG CONCENTRATE FOR SOLUTION FOR INFUSION
127219353 12721935 4 SS FLUOROBLASTIN FLUOROURACIL 1 Intravenous (not otherwise specified) 0 900 MG
127219353 12721935 5 SS FLUOROBLASTIN FLUOROURACIL 1 Intravenous (not otherwise specified) 0 900 MG
127219353 12721935 6 SS FLUOROBLASTIN FLUOROURACIL 1 Intravenous (not otherwise specified) 0 900 MG
127219353 12721935 7 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 0 100 MG
127219353 12721935 8 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 0 100 MG
127219353 12721935 9 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 0 100 MG
127219353 12721935 10 C EMEND APREPITANT 1 0 125 MG
127219353 12721935 11 C ONDANSETRON ONDANSETRON 1 0 8 MG
127219353 12721935 12 C DEXAMETHASONE. DEXAMETHASONE 1 Oral 0 16 MG
127219353 12721935 13 C KLEXANE ENOXAPARIN 1 Subcutaneous 0 60 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127219353 12721935 1 Rectal cancer
127219353 12721935 4 Rectal cancer
127219353 12721935 7 Rectal cancer
127219353 12721935 10 Prophylaxis of nausea and vomiting
127219353 12721935 11 Premedication
127219353 12721935 12 Premedication
127219353 12721935 13 Deep vein thrombosis

Outcome of event

Event ID CASEID OUTC COD
127219353 12721935 HO
127219353 12721935 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127219353 12721935 Abdominal pain upper
127219353 12721935 Hyperhidrosis
127219353 12721935 Nausea
127219353 12721935 Restlessness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127219353 12721935 1 20160802 0
127219353 12721935 2 20160705 0
127219353 12721935 3 20160704 0
127219353 12721935 4 20160802 0
127219353 12721935 5 20160705 0
127219353 12721935 6 20160704 0
127219353 12721935 7 20160802 0
127219353 12721935 8 20160705 0
127219353 12721935 9 20160704 0